Winrevair
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Winrevair in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Winrevair.
29
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Winrevair
A new restructuring programme has been approved to support the initiative
The drug has been authorised for use in adults with moderate or marked limitations of physical activity
Lagevrio is already available in the US under emergency use authorisation to treat certain cases of COVID-19
The progressive blood vessel disorder affects approximately 40,000 people in the US
Bladder cancer is the fifth most commonly diagnosed cancer in Europe, with more than 165,000 annual cases
About 30,000 people in the EU are living with the progressive blood vessel disorder
Approximately 30,000 people in the EU are currently living with the rare blood disorder
The approval represents the sixth lung cancer indication for the anti-PD-1 therapy in Europe
The rare blood vessel disorder affects approximately 500 to 1,000 people in the US every year
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology